Balyasny Asset Management’s Anterix ATEX Stock Holding History
Bought
Maintained
Sold
Other funds holding ATEX
OCAM
HCL
VCM
QF
PM
GI
Balyasny Asset Management's ATEX Position: Q1 2026 in Review
Balyasny Asset Management sold out of Anterix (ATEX) in Q1 2026, closing a stake of 17,740 shares — an estimated $387K sold.
Balyasny Asset Management first reported a position in ATEX in Q2 2024 and held it in 7 quarters. The position peaked at $2.82M in Q1 2025. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.
- Balyasny Asset Management reported no remaining Anterix position as of Q1 2026 after selling out during the quarter.
- Balyasny Asset Management sold 17,740 Anterix shares in Q1 2026, an estimated $387K.
- Balyasny Asset Management first reported a position in Anterix in Q2 2024 and held it in 7 quarters.
- Balyasny Asset Management's Anterix position peaked at $2.82M in Q1 2025.
- 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.
Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.